Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Report Code: BIO149E

Publish Date: May 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Report Includes

  • 14 data tables and 77 additional tables
  • Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
  • Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
  • Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
  • Discussion of emerging technologies, regulations and R&D efforts
  • Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
  • Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
  • Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
  • Overview of sustainability trends and ESG developments, including consumer attitudes, companies’ ESG score rankings and their ESG practices
  • Analysis of the competitive landscape, including companies’ market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
  • Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.

Report Scope

This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.

The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $166.4 million
Market size forecast $1.3 billion
Growth rate CAGR of 42.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered By Application, By Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Key Market Drivers
  • Increasing Investment in Biomedical Research
  • Trend Towards Precision Medicine
  • Technological Advancements in Exosome Research Tools
Companies studied
ACOUSORT ABAEGLE THERAPEUTICS
AETHLON MEDICAL INC.ARUNA BIO INC.
BIO-TECHNECAPRICOR THERAPEUTICS INC.
CARIS LIFE SCIENCESDIRECT BIOLOGICS LLC
EXOSOMICS SPAEVOX THERAPEUTICS LTD.
KIMERA LABSLONZA
MIR SCIENTIFICNANO MED
NANOSOMIXRION
SYSTEM BIOSCIENCES LLC
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global exosome diagnostics, therapeutics, and research tools and reagents market was estimated to be around $227.5 million in 2023. The market is projected to reach $1.3 billion in 2028, growing at a CAGR of 42.2% during the forecast period.
An in-depth analysis of the global exosome diagnostics, therapeutics, and research tools and reagents market, including historical data and market projection on sales by application, and region.
By application type, diagnostics and monitoring segment is anticipated to dominate the market by the end of 2028.
Diagnostics and monitoring is the fastest growing market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Exosome Diagnostics, Therapeutics and Research Tools: Global Markets101Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview6Free
Chapter- 3: Market Dynamics7Free
Chapter- 4: Regulatory Landscape 3Free
Chapter- 5: Emerging Technologies and Developments7Free
Chapter- 6: Market Segmentation Analysis34Free
Chapter- 7: Competitive Intelligence 7Free
Chapter- 8: Appendix 34Free
Published - Dec-2021| Analyst - BCC Publishing| Code - BIO149D

Report Highlights

The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.

Report Includes

  • 109 tables
  • An updated review of the global market for exosome diagnostics and therapeutics within the biotech research industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation and forecast the overall global market size, and corresponding market share analysis by application, end-user, and geographic region
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Evaluation of exosome proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Impact of exosome research on specific biopharmaceutical market and summary of details for major companies researching and producing exosome products
  • A relevant patent analysis on Exosome Diagnostics and Therapeutics in the U.S., Europe and Japan
  • Competitive landscape of the major players operating within global market, and their global rankings and company share analysis
  • Profile descriptions of the leading vendor companies including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics Inc., NonoSomiX Inc., and System Biosciences,
Published - Jun-2019| Analyst - Bhavna Joshi| Code - BIO149C

Report Highlights

The global market for exosome diagnostics and therapeutics should grow from $34.7 million in 2018 to $186.2 million by 2023, with a compound annual growth rate (CAGR) of 39.9% for the period of 2018-2023.

Report Includes

  • 106 tables
  • An overview of the global market for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Details of isolation and detection techniques and description of reagents and tools used for exosome research
  • Evaluation of exosomal proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Company profiles of the prominent players, including Codiak BioSciences, Evox Therapeutics Ltd., Exosome Diagnostics Inc., HansaBioMed Life Sciences Ltd. (Lonza), NonoSomiX Inc., and System Biosciences (SBI)
Published - Jun-2018| Analyst - Marianna Tcherpakov| Code - BIO149B

Report Highlights

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

Report Includes

  • 35 data tables and 35 additional tables
  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Breakdowns of new and existing diagnostic methods
  • Evaluations of current therapeutics and those likely to be utilized in the near future
  • Analyses of the market’s dynamics, specifically growth drivers, restraints, and opportunities
  • Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)
Published - Mar-2016| Analyst - Marianna Tcherpakov| Code - BIO149A

Report Highlights

The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%.

Report Includes

  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Breakdowns of new and exisiting diagnostic methods.
  • Evaluation of current therapeutics and those likely to be realized in the near future.
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.

Related Reports

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Next-Generation Cancer Diagnostics: Technologies and Global Markets

Published - Jun 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - BIO081D

The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
Sample Report